Skip to main content
Premium Trial:

Request an Annual Quote

Epic Sciences Receives CAP Accreditation

NEW YORK (GenomeWeb) – Epic Sciences announced today that its San Diego laboratory has received accreditation from the College of American Pathologists.

Epic markets a platform it calls "no cell left behind," which isolates circulating tumor cells in an unbiased manner, allowing downstream analyses of single CTCs using genomic, proteomic, and morphologic approaches.

CAP accreditation is designed to ensure a high standard of care for the laboratory testing of patient samples. As part of the process, CAP inspectors examine a lab's records and quality control of procedures, as well staff qualifications, equipment, facilities, safety records, and overall management.

Epic Sciences said it has analyzed more than 10,000 blood samples from cancer patients and that its technology is being used in more than 58 active clinical trials.

The company received CLIA certification for its lab in early 2015.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.